Cargando…

Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview

With improvement in living standards and average life expectancy, atherosclerotic cardiovascular disease incidences and mortality have been increasing annually. Paeonia suffruticosa, a natural herb, has been used for the treatment of atherosclerotic cardiovascular disease for thousands of years in E...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Min, Yu, Zongliang, Li, Xiaoya, Zhang, Xiaonan, Wang, Songzi, Yang, Shengjie, Hu, Lanqing, Liu, Longtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333700/
https://www.ncbi.nlm.nih.gov/pubmed/34368250
http://dx.doi.org/10.3389/fcvm.2021.690116
_version_ 1783733023091458048
author Wu, Min
Yu, Zongliang
Li, Xiaoya
Zhang, Xiaonan
Wang, Songzi
Yang, Shengjie
Hu, Lanqing
Liu, Longtao
author_facet Wu, Min
Yu, Zongliang
Li, Xiaoya
Zhang, Xiaonan
Wang, Songzi
Yang, Shengjie
Hu, Lanqing
Liu, Longtao
author_sort Wu, Min
collection PubMed
description With improvement in living standards and average life expectancy, atherosclerotic cardiovascular disease incidences and mortality have been increasing annually. Paeonia suffruticosa, a natural herb, has been used for the treatment of atherosclerotic cardiovascular disease for thousands of years in Eastern countries. Paeonol is an active ingredient extracted from Paeonia suffruticosa. Previous studies have extensively explored the clinical benefits of paeonol. However, comprehensive reviews on the cardiovascular protective effects of paeonol have not been conducted. The current review summarizes studies reporting on the protective effects of paeonol on the cardiovascular system. This study includes studies published in the last 10 years. The biological characteristics of Paeonia suffruticosa, pharmacological mechanisms of paeonol, and its toxicological and pharmacokinetic characteristics were explored. The findings of this study show that paeonol confers protection against atherosclerotic cardiovascular disease through various mechanisms, including inflammation, platelet aggregation, lipid metabolism, mitochondria damage, endoplasmic reticulum stress, autophagy, and non-coding RNA. Further studies should be conducted to elucidate the cardiovascular benefits of paeonol.
format Online
Article
Text
id pubmed-8333700
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83337002021-08-05 Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview Wu, Min Yu, Zongliang Li, Xiaoya Zhang, Xiaonan Wang, Songzi Yang, Shengjie Hu, Lanqing Liu, Longtao Front Cardiovasc Med Cardiovascular Medicine With improvement in living standards and average life expectancy, atherosclerotic cardiovascular disease incidences and mortality have been increasing annually. Paeonia suffruticosa, a natural herb, has been used for the treatment of atherosclerotic cardiovascular disease for thousands of years in Eastern countries. Paeonol is an active ingredient extracted from Paeonia suffruticosa. Previous studies have extensively explored the clinical benefits of paeonol. However, comprehensive reviews on the cardiovascular protective effects of paeonol have not been conducted. The current review summarizes studies reporting on the protective effects of paeonol on the cardiovascular system. This study includes studies published in the last 10 years. The biological characteristics of Paeonia suffruticosa, pharmacological mechanisms of paeonol, and its toxicological and pharmacokinetic characteristics were explored. The findings of this study show that paeonol confers protection against atherosclerotic cardiovascular disease through various mechanisms, including inflammation, platelet aggregation, lipid metabolism, mitochondria damage, endoplasmic reticulum stress, autophagy, and non-coding RNA. Further studies should be conducted to elucidate the cardiovascular benefits of paeonol. Frontiers Media S.A. 2021-07-21 /pmc/articles/PMC8333700/ /pubmed/34368250 http://dx.doi.org/10.3389/fcvm.2021.690116 Text en Copyright © 2021 Wu, Yu, Li, Zhang, Wang, Yang, Hu and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Wu, Min
Yu, Zongliang
Li, Xiaoya
Zhang, Xiaonan
Wang, Songzi
Yang, Shengjie
Hu, Lanqing
Liu, Longtao
Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
title Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
title_full Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
title_fullStr Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
title_full_unstemmed Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
title_short Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
title_sort paeonol for the treatment of atherosclerotic cardiovascular disease: a pharmacological and mechanistic overview
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8333700/
https://www.ncbi.nlm.nih.gov/pubmed/34368250
http://dx.doi.org/10.3389/fcvm.2021.690116
work_keys_str_mv AT wumin paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview
AT yuzongliang paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview
AT lixiaoya paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview
AT zhangxiaonan paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview
AT wangsongzi paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview
AT yangshengjie paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview
AT hulanqing paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview
AT liulongtao paeonolforthetreatmentofatheroscleroticcardiovasculardiseaseapharmacologicalandmechanisticoverview